US Census Bureau. Summary Social, Economic, and Housing Characteristics. Washington, DC: Government Printing Office; 2000.
2.
Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21:518-524.
3.
Harris MI, Klein R, Cowie CC, Rowland M, Byrd-Holt DD. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care. 1998;21:1230-1235.
4.
Young BA, Maynard C, Boyko EJ. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care. 2003;26:2392-2399.
5.
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069-1078.
6.
Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry. 2003;25:246-252.
7.
Cohen ST, Welch G, Jacobson AM, De Groot M, Samson J. The association of lifetime psychiatric illness and increased retinopathy in patients with type I diabetes mellitus. Psychosomatics. 1997;38:98-108.
8.
de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63:619-630.
9.
Hanninen JA, Takala JK, Keinanen-Kiukaanniemi SM. Depression in subjects with type 2 diabetes: predictive factors and relation to quality of life. Diabetes Care. 1999;22:997-998.
10.
Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care. 2000;23:618-623.
11.
Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G, Kahn HS. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol. 2005;161:652-660.
12.
Katon WJ, Rutter C, Simon G, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005;28:2668-2672.
13.
Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160:3278-3285.
14.
Jacobson AM, de Groot M, Samson JA. The effects of psychiatric disorders and symptoms on quality of life in patients with type I and type II diabetes mellitus. Qual Life Res. 1997;6:11-20.
Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression, and quality of life: a population study. Diabetes Care. 2004;27:1066-1070.
17.
Jerant AF, von Friederichs-Fitzwater MM, Moore M. Patients' perceived barriers to active self-management of chronic conditions. Patient Educ Couns. 2005;57:300-307.
18.
Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002;25:464-470.
19.
Katon WJ, Von Korff M, Lin EH, et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry. 2004;61:1042-1049.
20.
Lustman PJ, Griffith LS, Clouse RE, et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med. 1997;59:241-250.
21.
Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med. 1998;129: 613-621.
22.
Williams JW Jr, Katon W, Lin EH, et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med. 2004;140:1015-1024.
23.
Rubin RR, Ciechanowski P, Egede LE, Lin EH, Lustman PJ. Recognizing and treating depression in patients with diabetes. Curr Diab Rep. 2004;4:119-125.
24.
Shah ZC, Huffman FG. Depression among Hispanic women with type 2 diabetes. Ethn Dis. 2005;15:685-690.
25.
Black SA, Markides KS. Depressive symptoms and mortality in older Mexican Americans. Ann Epidemiol. 1999;9:45-52.
26.
Rubin RR, Knowler WC, Ma Y, et al. Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants. Diabetes Care. 2005;28:830-837.
27.
Gross R, Olfson M, Gameroff MJ, et al. Depression and glycemic control in Hispanic primary care patients with diabetes. J Gen Intern Med. 2005;20:460-466.
28.
Dwight-Johnson M, Sherbourne CD, Liao D, Wells KB. Treatment preferences among depressed primary care patients. J Gen Intern Med. 2000;15:527-534.
29.
Dwight-Johnson M, Lagomasino IT, Aisenberg E, Hay J. Using conjoint analysis to assess depression treatment preferences among low-income Latinos. Psychiatr Serv. 2004;55:934-936.
30.
Miranda J, Chung JY, Green BL, et al. Treating depression in predominantly low-income young minority women: a randomized controlled trial. JAMA. 2003;290:57-65.
31.
Miranda J, Cooper LA. Disparities in care for depression among primary care patients. J Gen Intern Med. 2004;19:120-126.
32.
Egede LE.Beliefs and attitudes of African Americans with type 2 diabetes toward depression. Diabetes Educ. 2002;28:258-268.
33.
Lewis-Fernandez R, Das AK, Alfonso C, Weissman MM, Olfson M. Depression in US Hispanics: diagnostic and management considerations in family practice. J Am Board Fam Pract. 2005;18:282-296.
34.
Cooper LA, Gonzales JJ, Gallo JJ, et al. The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients. Med Care. 2003;41:479-489.
35.
Krueger RA, Casey MA. Focus Groups: A Practical Guide for Applied Research. 3rd ed.Thousand Oaks, Calif: Sage; 2000.
Baranowski T, Perry C, Parcel GS. How Individuals, Environments and Health Behavior Interact: Social Cognitive Theory. 3rd ed.San Francisco, Calif: Jossey-Bass; 2002.
38.
Wulsin L, Somoza E, Heck J. The feasibility of using the Spanish PHQ-9 to screen for depression in primary care in Honduras. Prim Care Companion J Clin Psychiatry. 2002;4:191-195.
39.
Diez-Quevedo C, Rangil T, Sanchez-Planell L, Kroenke K, Spitzer RL. Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital Spanish inpatients. Psychosom Med. 2001;63:679-686.
40.
Miles MB, Huberman A. Qualitative Data Analysis. Thousand Oaks, Calif: Sage; 1994.
41.
Seidel J.Method and Madness in the Application of Computer Technology to Qualitative Data Analysis. London, UK: Sage; 1991.
42.
Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry. 2003;54:317-329.
43.
Coronado GD, Thompson B, Tejeda S, Godina R. Attitudes and beliefs among Mexican Americans about type 2 diabetes. J Health Care Poor Underserved. 2004;15:576-588.
44.
Ross CE, Mirowsky J, Cockerham WC. Social class, Mexican culture, and fatalism: their effects on psychological distress. Am J Community Psychol. 1983;11:383-399.
45.
Polonsky WH, Fisher L, Earles J, et al. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005;28:626-631.
46.
Lerman-Garber I, Barron-Uribe C, Calzada-Leon R, et al. Emotional dysfunction associated with diabetes in Mexican adolescents and young adults with type-1 diabetes. Salud Publica Mex. 2003;45:13-18.
47.
Fisher L, Chesla CA, Skaff MM, et al. The family and disease management in Hispanic and European-American patients with type 2 diabetes. Diabetes Care. 2000;23:267-272.
48.
Wen LK, Shepherd MD, Parchman ML. Family support, diet, and exercise among older Mexican Americans with type 2 diabetes. Diabetes Educ. 2004;30:980-993.
49.
Gleeson-Kreig J, Bernal H, Woolley S. The role of social support in the self-management of diabetes mellitus among a Hispanic population. Public Health Nurs. 2002;19:215-222.
50.
White NE, Richter JM, Fry C. Coping, social support, and adaptation to chronic illness. West J Nurs Res. 1992;14:211-224.
51.
Heilemann MV, Copeland D. Sources of emotional help sought by low income women of Mexican descent. Issues Ment Health Nurs. 2005;26:185-204.
52.
Sleath B, West S, Tudor G, Perreira K, King V, Morrissey J. Ethnicity and depression treatment preferences of pregnant women. J Psychosom Obstet Gynaecol. 2005;26:135-140.
53.
Kvam SH, Lyons JS. Assessment of coping strategies, social support, and general health status in individuals with diabetes mellitus. Psychol Rep. 1991;68:623-632.
54.
Bayliss EA, Steiner JF, Fernald DH, Crane LA, Main DS. Descriptions of barriers to self-care by persons with comorbid chronic diseases. Ann Fam Med. 2003;1:15-21.
55.
Kochhar R, Suro R, Tofaya S. The New Latino South: The Context and Consequences of Rapid Population Growth. Washington, DC: Pew Hispanic Center; 2005.
56.
Aikens JE, Bingham R, Piette JD. Patient-provider communication and self-care behavior among type 2 diabetes patients. Diabetes Educ. 2005;31:681-690.
57.
Vega WA, Kolody B, Aguilar-Gaxiola S, Catalano R. Gaps in service utilization by Mexican Americans with mental health problems. Am J Psychiatry. 1999;156:928-934.
58.
Williams JW Jr, Mulrow CD, Kroenke K, et al. Case-finding for depression in primary care: a randomized trial. Am J Med. 1999; 106:36-43.
59.
Kleinman A, Eisenberg L, Good B. Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med. 1978;88:251-258.